---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-006959"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T05:07:21.455094+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aethlon completes 1-for-10 reverse stock split to maintain Nasdaq listing

## Summary
- Reverse stock split approved by stockholders and board; ratio 1-for-10.
- Effective 5:00 p.m. ET on October 4, 2023; trading begins on split-adjusted basis October 5.
- Post-split outstanding shares approximately 2.5 million; new CUSIP 00808Y406.
- Purpose: meet Nasdaq minimum bid price requirement and continue capital market access.
- No fractional shares issued; stockholders receive full share for any fractional interest.

## SEC filing metadata
- accession: 0001683168-23-006959
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316823006959/0001683168-23-006959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316823006959/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-006959
- JSON: https://secwatch.observer/filing/0001683168-23-006959.json
- Plain text: https://secwatch.observer/filing/0001683168-23-006959.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.